Literature DB >> 16646076

2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9.

Yuichi Nakajima1, Misako Haraguchi, Tatsuhiko Furukawa, Masatatsu Yamamoto, Hayao Nakanishi, Masae Tatematsu, Shin-ichi Akiyama.   

Abstract

Thymidine phosphorylase (TP), an enzyme involved in pyrimidine metabolism, is identical with an angiogenic factor, platelet-derived endothelial cell growth factor. 2-Deoxy-D-ribose (D-dRib), the degradation product of thymidine generated by TP activity, has been suggested to be a downstream mediator of TP function. 2-Deoxy-L-ribose (L-dRib), a stereoisomer of D-dRib, inhibited the promotion of angiogenesis, tumor growth and metastasis by TP. In our study, we have shown that nude mice inoculated with TP-overexpressing KB/TP cells had shorter survival times than those injected with control KB/CV cells. KB/TP tumors were also more highly invasive than KB/CV tumors in mice. The expression levels of matrix metalloproteinase (MMP)-9 in KB/TP tumors were significantly higher than those in KB/CV tumors. L-dRib and a TP inhibitior, TPI, extended the survival period of KB/TP tumor-bearing mice. L-dRib also reduced MMP-9 mRNA levels in KB/TP tumors. Furthermore, L-dRib suppressed the mRNA level of MMP-9 in cultured KB/TP cells, and the invasive activity of the cells. L-dRib may be useful for the suppression of invasion of TP-expressing tumor cells. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16646076     DOI: 10.1002/ijc.22014

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

Review 1.  Thymidine Phosphorylase in Cancer; Enemy or Friend?

Authors:  Yasir Y Elamin; Shereen Rafee; Nemer Osman; Kenneth J O Byrne; Kathy Gately
Journal:  Cancer Microenviron       Date:  2015-08-23

2.  Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma.

Authors:  Jongkonnee Thanasai; Temduang Limpaiboon; Patcharee Jearanaikoon; Banchob Sripa; Chawalit Pairojkul; Srisurang Tantimavanich; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

3.  Thymidine phosphorylase promotes metastasis and serves as a marker of poor prognosis in hepatocellular carcinoma.

Authors:  Qiang Zhang; Yang Zhang; Xuejiao Hu; Yuan Qin; Weilong Zhong; Jing Meng; Ting Xiao; Chunhong Zhang; Meng Li; Shuang Chen; Huijuan Liu; Yanrong Liu; Tao Sun; Cheng Yang
Journal:  Lab Invest       Date:  2017-05-22       Impact factor: 5.662

4.  Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors.

Authors:  I V Bijnsdorp; F Capriotti; F A E Kruyt; N Losekoot; M Fukushima; A W Griffioen; V L Thijssen; G J Peters
Journal:  Br J Cancer       Date:  2011-03-08       Impact factor: 7.640

5.  Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients.

Authors:  A Abajo; V Boni; I Lopez; M Gonzalez-Huarriz; N Bitarte; J Rodriguez; R Zarate; E Bandres; J Garcia-Foncillas
Journal:  Br J Cancer       Date:  2012-06-14       Impact factor: 7.640

Review 6.  The dual role of thymidine phosphorylase in cancer development and chemotherapy.

Authors:  Annelies Bronckaers; Federico Gago; Jan Balzarini; Sandra Liekens
Journal:  Med Res Rev       Date:  2009-11       Impact factor: 12.944

Review 7.  Developing Wound Dressings Using 2-deoxy-D-Ribose to Induce Angiogenesis as a Backdoor Route for Stimulating the Production of Vascular Endothelial Growth Factor.

Authors:  Serkan Dikici; Muhammad Yar; Anthony J Bullock; Joanna Shepherd; Sabiniano Roman; Sheila MacNeil
Journal:  Int J Mol Sci       Date:  2021-10-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.